APOPTOTIC SIGNALING THROUGH CD95 (FAS/APO-1) ACTIVATES AN ACIDIC SPHINGOMYELINASE

被引:508
|
作者
CIFONE, MG
DEMARIA, R
RONCAIOLI, P
RIPPO, MR
AZUMA, M
LANIER, LL
SANTONI, A
TESTI, R
机构
[1] UNIV ROMA LA SAPIENZA,DEPT EXPTL MED,I-00161 ROME,ITALY
[2] UNIV ROMA TOR VERGATA,DEPT EXPTL MED & BIOCHEM SCI,I-00161 ROME,ITALY
[3] UNIV LAQUILA,DEPT EXPTL MED,I-67100 LAQUILA,ITALY
[4] DNAX RES INST MOLEC & CELLULAR BIOL INC,DEPT HUMAN IMMUNOL,PALO ALTO,CA 94304
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1994年 / 180卷 / 04期
关键词
D O I
10.1084/jem.180.4.1547
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intracellular pathways leading from membrane receptor engagement to apoptotic cell death are still poorly characterized. We investigated the intracellular signaling generated after cross-linking of CD95 (Fas/Apo-1 antigen), a broadly expressed cell surface receptor whose engagement results in triggering of cellular apoptotic programs. DX2, a new functional anti-CD95 monoclonal antibody was produced by immunizing mice with human CD95-transfected L cells. Crosslinking of CD95 with DX2 resulted in the activation of a sphingomyelinase (SMase) in promyelocytic U937 cells, as well as in other human tumor cell lines and in CD95-transfected murine cells, as demonstrated by induction of in vivo sphingomyelin (SM) hydrolysis and generation of ceramide. Direct in vitro measurement of enzymatic activity within CD95-stimulated U937 cell extracts, using labeled SM vesicles as substrates, showed strong SMase activity, which required pH 5.0 for optimal substrate hydrolysis. Finally, all CD95-sensitive cell lines tested could be induced to undergo apoptosis after exposure to cell-permeant C-2-ceramide. These data indicate that CD95 cross-linking induces SM breakdown and ceramide production through an acidic SMase, thus providing the first information regarding early signal generation from CD95, and may be relevant in defining the biochemical nature of intracellular messengers leading to apoptotic cell death.
引用
收藏
页码:1547 / 1552
页数:6
相关论文
共 50 条
  • [1] Fas/CD95/Apo-I activates the acidic sphingomyelinase via Caspases
    Brigit Brenner
    Klaus Ferlinz
    Heike Grassmé
    Michael Weller
    Ursula Koppenhoefer
    Johannes Dichgans
    Konrad Sandhoff
    Florian Lang
    Erich Gulbins
    Cell Death & Differentiation, 1998, 5 : 29 - 37
  • [2] Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases
    Brenner, B
    Ferlinz, K
    Grassmé, H
    Weller, M
    Koppenhoefer, U
    Dichgans, J
    Sandhoff, K
    Lang, F
    Gulbins, E
    CELL DEATH AND DIFFERENTIATION, 1998, 5 (01): : 29 - 37
  • [3] Two CD95 (APO-1/Fas) signaling pathways
    Scaffidi, C
    Fulda, S
    Srinivasan, A
    Friesen, C
    Li, F
    Tomaselli, KJ
    Debatin, KM
    Krammer, PH
    Peter, ME
    EMBO JOURNAL, 1998, 17 (06): : 1675 - 1687
  • [4] Defective apoptotic signaling through CD95 (Fas/Apo-1) in insulin-dependent diabetes mellitus
    Todaro, M
    Stassi, G
    DeMaria, R
    Richiusa, P
    Mattina, A
    Galluzzo, A
    Giordano, C
    DIABETES, 1996, 45 : 194 - 194
  • [5] The CD95(APO-1/Fas) DISC and beyond
    M E Peter
    P H Krammer
    Cell Death & Differentiation, 2003, 10 : 26 - 35
  • [6] CD95(apo-1/fas) signalling and diseases
    Krammer, PH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R1 - R1
  • [7] The CD95(APO-1/Fas) DISC and beyond
    Peter, ME
    Krammer, PH
    CELL DEATH AND DIFFERENTIATION, 2003, 10 (01): : 26 - 35
  • [8] The CD95(APO-1/Fas)/CD95L system
    Krammer, PH
    TOXICOLOGY LETTERS, 1998, 103 : 131 - 137
  • [9] The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
    Vaishnaw, AK
    Orlinick, JR
    Chu, JL
    Krammer, PH
    Chao, MV
    Elkon, KB
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03): : 355 - 363
  • [10] Characterization of Fas (Apo-1, CD95)-Fas ligand interaction
    Schneider, P
    Bodmer, JL
    Holler, N
    Mattmann, C
    Scuderi, P
    Terskikh, A
    Peitsch, MC
    Tschopp, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18827 - 18833